USDA APHIS and Its Role in US Animal Health
The Animal and Plant Health Inspection Service — better known as APHIS — sits at the center of how the United States monitors, protects, and responds to threats affecting animal populations, from backyard chickens to commercial cattle operations to imported exotic species. This page covers what APHIS actually does, how its regulatory machinery operates day to day, the situations where it becomes most relevant for animal owners and producers, and where its authority ends and other agencies begin. For anyone trying to understand the broader landscape of animal health in the US, APHIS is an unavoidable starting point.
Definition and scope
APHIS is a branch of the U.S. Department of Agriculture established to protect American agriculture and natural resources from pests, diseases, and other biological threats. Its mandate spans domestic animal health, veterinary biologics licensing, import and export controls, wildlife damage management, and animal welfare enforcement — a combination that makes it one of the more structurally unusual federal agencies, covering everything from the licensing of rabies vaccines to the regulation of circuses.
The agency operates through seven distinct program areas. The two most relevant to animal health are:
- Veterinary Services (VS) — Oversees domestic and international animal disease prevention, surveillance, and emergency response. VS manages the National Animal Health Reporting System and coordinates with state veterinarians on disease control programs.
- Wildlife Services (WS) — Addresses conflicts between wildlife and human activities, including disease management in wild animal populations such as feral swine, which the USDA identifies as carriers of at least 30 diseases transmissible to livestock and humans (USDA APHIS Wildlife Services).
APHIS also houses the Center for Veterinary Biologics (CVB), which regulates the production and sale of veterinary vaccines, bacterins, antisera, and diagnostic kits. A product cannot legally be sold in interstate commerce as a veterinary biologic without CVB licensure — a requirement that shapes the entire domestic animal pharmaceutical market.
How it works
APHIS regulatory authority flows primarily from two statutes: the Animal Health Protection Act of 2002, which governs disease control and import restrictions, and the Virus-Serum-Toxin Act of 1913, which remains the legal foundation for biologics oversight more than a century after its passage (Animal Health Protection Act, 7 U.S.C. §§ 8301–8322).
In practice, VS operates a layered surveillance architecture. At the foundation sit accredited veterinarians — private practitioners who have completed federal training and are authorized to perform official testing, issue health certificates, and report notifiable diseases. Above them are State Animal Health Officials, who manage state-level disease programs and report upward to APHIS. Federal veterinarians at ports of entry form a parallel track, inspecting animals and animal products crossing US borders.
When a foreign animal disease is suspected — foot-and-mouth disease being the classic example — the response protocol escalates rapidly. APHIS can impose Federal Quarantine Orders, restrict interstate movement of animals, and depopulate affected herds. The 2015 highly pathogenic avian influenza (HPAI) outbreak triggered the largest animal disease response in US history, resulting in the depopulation of approximately 50.5 million birds (USDA APHIS HPAI Response).
Common scenarios
APHIS touches animal owners in ways that aren't always obvious until a specific situation arises. The most common points of contact include:
- Interstate transport: Moving livestock, horses, or certain companion animals across state lines requires a Certificate of Veterinary Inspection (CVI) issued by an APHIS-accredited veterinarian. Requirements vary by species and destination state.
- Import and export: Anyone importing a dog from outside the US must comply with APHIS and CDC requirements simultaneously. Dogs imported for resale or adoption face vaccination documentation requirements that became significantly stricter in 2022 following a CDC suspension of high-risk country imports.
- Disease reporting: If a veterinarian identifies a zoonotic disease or a condition on the APHIS reportable disease list — including brucellosis, vesicular stomatitis, or classical swine fever — mandatory reporting flows through the accredited vet to the state veterinarian and, depending on severity, to APHIS Federal Veterinarians.
- Biologics licensing: A company developing a new canine influenza vaccine, for instance, must submit serial testing data, conduct efficacy studies, and obtain a product license from the CVB before commercial release. This process routinely takes 18 to 36 months.
For those working in livestock and farm animal health, APHIS program participation — such as the Brucellosis Eradication Program or the Scrapie Eradication Program — may be required to access certain markets or maintain state-certified herd status.
Decision boundaries
APHIS authority is broad but not unlimited, and understanding its edges matters for both compliance and advocacy.
APHIS governs animal health and trade — not animal welfare in the general sense. Welfare for research animals falls under the Animal Welfare Act, which APHIS does enforce through its Animal Care program, but cruelty in private settings is a state-law matter entirely outside APHIS jurisdiction. The FDA controls veterinary drugs through the Center for Veterinary Medicine; APHIS controls biologics through CVB. The line between a drug and a biologic can be surprisingly fine — monoclonal antibodies in veterinary medicine have historically created jurisdictional tension between the two agencies.
State authority adds another layer. States retain primary authority over intrastate animal movement and many disease control programs. APHIS functions through cooperative agreements with state animal health agencies, meaning federal and state authority overlap intentionally in US animal health regulations. When conflicts arise — say, a state wanting to maintain a different disease-free status than APHIS recognizes — resolution requires negotiation, not automatic federal preemption.
For anyone tracking antimicrobial resistance in animals or animal disease trends broadly, APHIS surveillance data, published through the National Animal Health Monitoring System (NAHMS), represents one of the most comprehensive longitudinal datasets available on US livestock health.
References
- USDA APHIS Official Site
- USDA APHIS Veterinary Services
- USDA APHIS Center for Veterinary Biologics
- USDA APHIS Wildlife Services
- Animal Health Protection Act, 7 U.S.C. §§ 8301–8322
- Virus-Serum-Toxin Act, 21 U.S.C. §§ 151–159
- USDA APHIS HPAI Response and Detections
- USDA National Animal Health Monitoring System (NAHMS)